Early-life supplementation of Bifidobacterium infantis and 2’-fucosyllactose revives gut microbiota perturbation, intestinal development delay, and promotes immune function following the ceftriaxone challenge

This database contains body weight, colon crypt depth, intestinal Ki-67 ( + ) count, fecal bifidobacteria qPCR quantification, cecal short-chain fatty acids, spleen inflammatory factors, and antibody content determination results.